19/05/2025
The Third SCN8A and SCN2A International Conference & family Gathering saw the participation of 130 attendees, among clinicians, researchers and families, from more than 20 countries around the world.
The coordination of the clinicians Walid Fazeli and Elena Gardella allowed, as in previous years, to create a high scientific level and very constructive meeting.
The format of a joint conference, with the two paralogous genes, SCN8A and SCN2A, groups, which we started as a pilot project in 2021, has been consecrated as very successful, both by all the academics and the pharmaceutical companies attending. took care of all the organization.
The Dianalund group, led by Elena Gardella and Rikke Moller, confirms itself as a world leader in the study of the SCN8A mutation, with an impressive scientific production in terms of new data collected and scientific publications. The Dianalund group is also the leader and coordinator of the Natural History Study of the SCN8A mutation, which includes data of more than 800 patients worldwide, collected directly from the hospitals. It is a huge work, instrumental for the clinical development of new drugs.
New ideas, projects and collaborations raised and will be presented at the next International Conference dedicated to SCN8A and SCN2A mutations, in 2027 in Denmark.
Cinzia Scarcelli
SCN8A Italia ODV President
